Interestingly, increased levels of BDNF, NGF, and NT-3 in the injured spinal cord may be the main therapeutic effect of using hUCB-MSCs to treat spinal cord injuries (SCI) [67]. The gene discussed is NGF; the disease is spinal cord injury.